XML 41 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business segment information (Tables)
12 Months Ended
Dec. 31, 2012
Business Segments by GBU

Business Segments by GBU:

The table below presents external net sales for continuing operations by GBU reporting segment. Net sales includes product sales and marketing service fees which is comprised of sales of Trinity Evolution® in spine and orthopedic applications.

 

     External Net Sales by GBU
Year ended December 31,
 
(US$ in thousands)    2012     2011     2010  
     Net Sales      Percent of
Total Net
Sales
    Net Sales      Percent of
Total Net
Sales
    Net Sales      Percent of
Total Net
Sales
 

Spine

               

Spine Repair Implants and Regenerative Biologics

   $ 147,206         32   $ 143,775         31   $ 133,831         29

Spine Regenerative Stimulation

     164,688         35     160,442         34     172,573         38
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total Spine

     311,894         67     304,217         65     306,404         67

Orthopedics

     150,426         33     165,904         35     154,225         33
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total Net Sales

   $ 462,320         100   $ 470,121         100   $ 460,629         100
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 
Operating Income (Loss) by GBU
     Operating Income  (Loss)
Year Ended December 31,
 

(US$ in thousands)

   2012     2011     2010  

Spine (1)

   $ 90,771      $ 46,618      $ 80,688   

Orthopedics (2)

     15,280        12,368        5,878   

Corporate (3)

     (17,041     (27,677     (20,316
  

 

 

   

 

 

   

 

 

 

Total

   $ 89,010      $ 31,309      $ 66,250   
  

 

 

   

 

 

   

 

 

 

 

(1) For 2011, the operating income for the Spine GBU included $42.5 million of expenses in connection with charges related to U.S. Government resolutions.
(2) For 2011, the operating income for the Orthopedics GBU included $6.5 million of expenses in connection with charges related to U.S. Government resolutions.
(3) For 2011, the operating loss for the Corporate GBU included $7.5 million of expenses in connection with charges related to U.S. Government inquiries and $3.2 million of senior management succession charges.
Selected Financial Information by Reporting Segment

The following table presents depreciation and amortization for continuing operations by GBU reporting segment:

 

     Depreciation and amortization by GBU
Year Ended December 31,
 

(US$ in thousands)

   2012      2011      2010  

Spine

   $ 12,152       $ 11,060       $ 9,407   

Orthopedics

     5,604         5,506         6,282   

Corporate

     70         52         126   
  

 

 

    

 

 

    

 

 

 

Total

   $ 17,826       $ 16,618       $ 15,815   
  

 

 

    

 

 

    

 

 

 
Summary of Net Sales by Geographic Destination

Analysis of net sales by geographic destination:

 

(US$ in thousands)

   2012      2011      2010  

U.S.

   $ 341,015       $ 329,625       $ 339,781   

International:

        

U.K.

     8,628         8,240         12,509   

Italy

     18,242         20,700         19,831   

Brazil

     38,015         48,851         29,067   

Other

     56,420         62,705         59,441   
  

 

 

    

 

 

    

 

 

 

Total international

     121,305         140,496         120,848   
  

 

 

    

 

 

    

 

 

 

Total net sales

   $ 462,320       $ 470,121       $ 460,629   
  

 

 

    

 

 

    

 

 

 
Analysis of Property, Plant and Equipment of Reporting Segments by Geographic Area

Analysis of property, plant and equipment by geographic area:

 

(US$ in thousands)

   2012      2011  

U.S.

   $ 37,081       $ 30,806   

Italy

     7,617         7,663   

U.K.

     1,402         1,449   

Brazil

     3,421         2,532   

Others

     1,841         918   
  

 

 

    

 

 

 

Total

   $ 51,362       $ 43,368